Literature DB >> 18712983

Survival rates and prognosis of gastric cancer using an actuarial life-table method.

Bijan Moghimi-Dehkordi1, Azadeh Safaee, Mohammad Reza Zali.   

Abstract

BACKGROUND AND AIMS: The aim of this study was to calculate survival rates and analyze patterns of survival in gastric cancer.
METHODS: A total number of 746 patients with gastric cancer registered in the Cancer Registry Center of Research Center of Gastroenterology and Liver Disease of Shahid Beheshti University of Medical Sciences, Iran, from Dec 21, 2001 to Dec 21, 2006 were investigated. 1- to 5-year survival rates were estimated using life-table method and compared by Wilcoxon (Gehan) test. P<0.05 was considered as statistically significant. All calculations were carried out with SPSS (version 13.0) statistical software.
RESULTS: There were 530 male patients with a mean age of 60.5+/-12.6 years and 216 females with a mean age of 57.5+/-13.5 years. Of the total, 454 died and 285 were censored during the investigation. The median survival time was 24.2 months and survival rates at one, two, third, fourth and five years after diagnosis were 73.6, 50.2, 40.6, 33.2 and 29.7%, respectively. Stages of tumor, histology grade, histologic type of cancer, tumor size, age at diagnosis and surgery approach were independent prognostic factors . However, variables such as sex (P=.533), body mass index (P=.214), ethnicity (P=.092), and level of education (P=.762) did not shown significant effects on survival.
CONCLUSION: Early detection of patients at lower age and with primary stages and grades of tumor is important to increase patient's life expectancy.

Entities:  

Mesh:

Year:  2008        PMID: 18712983

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  9 in total

1.  The effect of oxamflatin on the E-cadherin expression in gastric cancer cell line.

Authors:  E Faghihloo; Y Araei; M Mohammadi; H Mirzaei; H R Mohammadi; T Mokhtari-Azad
Journal:  Cancer Gene Ther       Date:  2016-10-21       Impact factor: 5.987

2.  Over-expression of Metastasis-associated in Colon Cancer-1 (MACC1) Associates with Better Prognosis of Gastric Cancer Patients.

Authors:  Shao-Hua Ge; Xiao-Jiang Wu; Xiao-Hong Wang; Xiao-Fang Xing; Lian-Hai Zhang; Yu-Bing Zhu; Hong Du; Bin Dong; Ying Hu; Jia-Fu Ji
Journal:  Chin J Cancer Res       Date:  2011-06       Impact factor: 5.087

Review 3.  Diagnostic accuracy of circulating tumor cells detection in gastric cancer: systematic review and meta-analysis.

Authors:  Lanhua Tang; Shushan Zhao; Wei Liu; Nicholas F Parchim; Jin Huang; Youhong Tang; Pingping Gan; Meizuo Zhong
Journal:  BMC Cancer       Date:  2013-06-27       Impact factor: 4.430

4.  The presence of metastases in regional lymph nodes is associated with tumor size and depth of invasion in sporadic gastric adenocarcinoma.

Authors:  Eduardo Cambruzzi; Andreza Mariane de Azeredo; Ardala Kronhart; Katia Martins Foltz; Claudio Galeano Zettler; Karla Lais Pêgas
Journal:  Arq Bras Cir Dig       Date:  2014 Jan-Mar

5.  Estimating the Net Survival of Patients with Gastric Cancer in Iran in a Relative Survival Framework.

Authors:  Fatemeh Paknazar; Mahmood Mahmoudi; Kazem Mohammad; Hojjat Zeraati; Mohammad Ali Mansournia; Mahdi Yaseri
Journal:  Iran J Med Sci       Date:  2018-11

6.  Family History as a Risk for Upper Gastrointestinal Tract Cancer: A Case Control Study.

Authors:  A Safaee; B Moghimi Dehkordi; S R Fatemi; E Maserat; F Ghafarnejad; M R Zali
Journal:  Iran J Cancer Prev       Date:  2011

7.  Mortality trends of gastrointestinal cancers in Iranian population.

Authors:  Mohamad Amin Pourhoseingholi; Zeinab Fazeli; Sara Ashtari; Fatemeh Sadat Fazeli Bavand-Pour
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013

Review 8.  Survival rate of gastric cancer in Iran; a systematic review and meta-analysis.

Authors:  Yousef Veisani; Ali Delpisheh
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016

Review 9.  Epidemiologic Study of Gastric Cancer in Iran: A Systematic Review.

Authors:  Khadijeh Kalan Farmanfarma; Neda Mahdavifar; Soheil Hassanipour; Hamid Salehiniya
Journal:  Clin Exp Gastroenterol       Date:  2020-11-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.